Marathon Trading Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Marathon Trading Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,220	Closed	-$46.1K	–	357
2024 Q2	$46.1K	Buy	+20,220	New	+$77.2K	﹤0.01%	253

Marathon Trading Investment Management's GTHX Position: Q3 2024 in Review

Marathon Trading Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 20,220 shares — an estimated $46.1K sold.

Marathon Trading Investment Management first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $46.1K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Marathon Trading Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Marathon Trading Investment Management sold 20,220 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $46.1K.
Marathon Trading Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Marathon Trading Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $46.1K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Marathon Trading Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.